Oncomed Pharma (OMED)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | OMED | AZN | AMGN | GILD | BMY |
| Company | Oncomed Pharma | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 0.93 | 180.58 | 345.87 | 130.57 | 55.75 |
| High | 0.93 | 182.67 | 349.18 | 131.04 | 56.77 |
| Low | 0.93 | 180.24 | 343.34 | 128.23 | 55.66 |
| Latest | 0.93 | 182.21 | 344.32 | 128.26 | 55.91 |
| Change | +0.04 | +5.93 | +6.10 | -0.73 | +1.19 |
| % Change | +4.49% | +3.36% | +1.80% | -0.57% | +2.17% |
| Volume | 1,201 | 627,041 | 684,028 | 2,061,878 | 3,529,112 |
| 20-Day Average Volume | 777,535 | 1,819,498 | 2,332,102 | 6,597,645 | 10,699,947 |
| Previous Close | 0.89 | 176.28 | 338.22 | 128.99 | 54.72 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.02 | 183.93 | 333.73 | 131.94 | 56.88 |
| 20-Day Raw Stochastic | 24.44% | 46.12% | 84.33% | 16.92% | 30.58% |
| 20-Day Relative Strength | 48.64 | 45.04 | 53.90 | 42.49 | 45.05 |
| Weighted Alpha | -62.95 | +19.32 | +17.04 | +10.75 | +15.42 |
| Today's Opinion | 24% Sell | 24% Sell | 8% Buy | 40% Sell | 8% Sell |
| Previous Opinion | 40% Sell | 40% Sell | 24% Sell | 24% Sell | 24% Sell |
| Last Month's Opinion | 40% Sell | 8% Buy | 8% Sell | 8% Buy | 24% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -8.82% since 04/16/19 | -1.58% since 05/28/26 | +2.41% since 05/28/26 | -5.42% since 05/28/26 | -1.51% since 05/28/26 |
| Low | 0.82 on 04/17/19 | 174.60 on 06/03/26 | 322.30 on 06/02/26 | 127.07 on 06/02/26 | 54.20 on 06/02/26 |
| High | 1.27 on 04/17/19 | 187.10 on 05/29/26 | 348.98 on 06/04/26 | 137.20 on 05/29/26 | 57.45 on 06/01/26 |
| 1-Month | |||||
| %Chg | +5.26% since 03/22/19 | -0.58% since 05/04/26 | +6.40% since 05/04/26 | -2.91% since 05/04/26 | -2.32% since 05/04/26 |
| Low | 0.82 on 04/17/19 | 174.60 on 06/03/26 | 320.52 on 05/05/26 | 127.07 on 06/02/26 | 54.20 on 06/02/26 |
| High | 1.27 on 04/17/19 | 191.50 on 05/21/26 | 348.98 on 06/04/26 | 137.50 on 05/12/26 | 60.25 on 05/22/26 |
| 3-Month | |||||
| %Chg | +27.40% since 01/23/19 | -9.49% since 03/04/26 | -9.14% since 03/04/26 | -13.08% since 03/04/26 | -10.08% since 03/04/26 |
| Low | 0.71 on 02/11/19 | 174.60 on 06/03/26 | 320.52 on 05/05/26 | 127.07 on 06/02/26 | 54.20 on 06/02/26 |
| High | 1.27 on 04/17/19 | 207.30 on 04/10/26 | 380.14 on 03/11/26 | 149.38 on 03/10/26 | 62.22 on 04/01/26 |
| 6-Month | |||||
| %Chg | -55.50% since 10/23/18 | +1.30% since 12/04/25 | +1.30% since 12/04/25 | +5.07% since 12/04/25 | +7.89% since 12/04/25 |
| Low | 0.55 on 12/26/18 | 174.60 on 06/03/26 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 50.33 on 12/10/25 |
| High | 2.14 on 10/24/18 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 34,434 | 273,394,048 | 182,540,032 | 160,150,112 | 111,742,128 |
| Shares Outstanding, K | 38,690 | 1,550,908 | 539,708 | 1,241,570 | 2,042,071 |
| Annual Sales | 44,420,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -8,100,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 10,180,000 | 15,288,000,000 | 8,618,000,000 | 6,960,000,000 | 11,489,000,000 |
| Last Quarter Net Income | -4,670,000 | 3,080,000,000 | 1,819,000,000 | 2,021,000,000 | 2,677,000,000 |
| 60-Month Beta | 1.86 | 0.25 | 0.42 | 0.31 | 0.24 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 2.58 on 04/29/26 | 5.15 on 04/30/26 | 2.03 on 05/07/26 | 1.58 on 04/30/26 |
| Earnings Date | 05/14/19 | 08/04/26 | 08/04/26 | 08/06/26 | 07/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 05/15/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 06/15/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 19.16 | 14.85 | 15.24 | 9.18 |